CSL LIMITED

CSL

equity

AUD $299.02

3.77 (1.28%)

Updated: 20 Jan, 5:10 am UTC

Description

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.

Activity
Last price		$299.02
Change		3.77 (1.28%)
Bid/Ask		$297.90 - $299.05
Volume		1.14M
Volume traded/total %		0.24%
Volume avg (4w)		630,153.00
Open		$295.00
Day range		$293.64 - $299.02
Previous Close		$295.25
Last Trade		20 Jan, 5:10 am UTC

Size
Market Cap		$142.37B
Market Rank		3
Industry Rank		1

Fundamentals
Shares Issued		482.22M
Earnings Per Share (EPS)		$6.98
Dividends Per Share (DPS)		$3.18
P/E Ratio		42.83

Similar to